- Lobbying
- Jill AND Keller
Lobbying Arrangements Results for 'Jill Keller'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Resolution of a contract dispute. |
Globex International, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to economic development in the Palestinian territories. |
Palestine Investment Fund
|
DLA Piper LLP (US) | |||
Details Policies with respect to electricity transmission and smart grid technologies. |
Landis + Gyr
|
DLA Piper LLP (US) | |||
Details Efforts to treat and prevent emerging infectious diseases. |
Schiltz Foods, Inc.
|
DLA Piper LLP (US) | |||
Details S. 2248, Foreign Intelligence Surveillance Amendments Act of 2007. |
Verizon Communications
|
DLA Piper LLP (US) | |||
Details Implementation of Public Law No. 111-148, provisions related to health IT. |
Aetna, Inc.
|
DLA Piper LLP (US) | |||
Details H.R. 1851/S. 881, Family Act of 2013. S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality an... |
EMD Serono, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to the Hatch-Waxman Act. |
THE MEDICINES COMPANY
|
DLA Piper LLP (US) | |||
Details Pandemic influenza, vaccine-related issues. Tax issues impacting pharmacies. H.R. 475, to amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definitio... |
SANOFI PASTEUR
|
DLA Piper LLP (US) | |||
Details Deployment of and appropriations for high-speed rail technology in the United States. H.R. 4450, Departments of Transportation, Housing and Urban Development, and Related Agencies Appropriations Ac... |
The Northeast MAGLEV, LLC
|
DLA Piper LLP (US) | |||
Details Legislative and regulatory issues affecting the financial services industry and issues relating to student lending policy. |
Discover Financial Services, Inc.
|
DLA Piper LLP (US) | |||
Details Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S... |
Novo Nordisk Inc.
|
DLA Piper LLP (US) | |||
Details H.R. 4365/S. 2587, Department of Defense Appropriations Act, FY2024, provisions related to engine and missle issues. H.R. 2670/S. 2226, National Defense Authorization Act for FY2024, provisions rel... |
RTX Corporation and Affiliates
|
DLA Piper LLP (US) |